BC Innovations | May 19, 2016
Distillery Therapeutics

Therapeutics: Sirtuin 6 (SIRT6); lin-28 homolog B (LIN28B)

Cancer INDICATION: Pancreatic cancer Patient sample, cell culture and mouse studies suggest inhibiting LIN28B could help treat pancreatic ductal adenocarcinomas (PDACs) harboring loss-of-function SIRT6 mutations. In 30-40% of PDAC patients, SIRT6 levels were lower in...
BC Innovations | Jun 11, 2009
Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Cancer Lin-28 homolog (LIN28); Lin-28 homolog B (LIN28B) In vitro studies suggest that targeting LIN28 and LIN28B could help treat cancer....
Items per page:
1 - 2 of 2